New technology for identifying respiratory viruses
ResVir Novel Technologies for Respiratory Virus Identification
This study is testing a new technology that quickly identifies different respiratory viruses from throat swabs to see if it can help doctors manage infections better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | All |
| Sponsor | Portsmouth Hospitals NHS Trust Government |
| Locations | 1 site (Portsmouth, Hampshire) |
| Trial ID | NCT05661032 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of the Pictura Bio system, a novel rapid pathogen identification technology, in detecting and differentiating respiratory viruses from nasopharyngeal swabs. The study will collect data to train algorithms that enhance the accuracy of virus identification. By monitoring the system's performance over time, researchers hope to improve its sensitivity and specificity for clinical use. The ultimate goal is to provide a rapid, cost-effective diagnostic tool that can help manage respiratory infections more effectively.
Who should consider this trial
Good fit: Ideal candidates include individuals with clinical suspicion of a respiratory viral infection who can provide nasopharyngeal swab specimens.
Not a fit: Patients who are unable to provide nasopharyngeal swabs or those lacking the capacity to consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this technology could lead to faster and more accurate diagnoses of respiratory infections, reducing unnecessary antibiotic use and improving patient outcomes.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in improving rapid virus detection methods.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provide informed, (parental/guardian, where appropriate) consent * Able to provide nasopharyngeal swab/aspirate specimens. * A clinical suspicion of a respiratory viral infection with one or more of the following symptoms: * Coryzal symptoms (runny nose, sneezing and/or nasal congestion) * New onset of cough * Sore throat * Head and/or Muscle aches * Fever or chills Exclusion Criteria: * Unable to comply with study procedures or where in the opinion of the investigator, undertaking a nasopharyngeal swab may be detrimental to the individual * Lacking capacity to consent
Where this trial is running
Portsmouth, Hampshire
- Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital — Portsmouth, Hampshire, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Sharon Glaysher, Dr — Portsmouth University Hospital NHS Trust
- Study coordinator: Yvette Hibberd
- Email: Yvette.hibberd@porthosp.nhs.uk
- Phone: 023 9228 6000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.